Title |
Biosynthesis of trans-4-hydroxyproline by recombinant strains of Corynebacterium glutamicum and Escherichia coli
|
---|---|
Published in |
BMC Biotechnology, May 2014
|
DOI | 10.1186/1472-6750-14-44 |
Pubmed ID | |
Authors |
Yulan Yi, Huakai Sheng, Zhimin Li, Qin Ye |
Abstract |
Trans-4-hydroxy-L-proline (trans-Hyp), one of the hydroxyproline (Hyp) isomers, is a useful chiral building block in the production of many pharmaceuticals. Although there are some natural biosynthetic pathways of trans-Hyp existing in microorganisms, the yield is still too low to be scaled up for industrial applications. Until now the production of trans-Hyp is mainly from the acid hydrolysis of collagen. Due to the increasing environmental concerns on those severe chemical processes and complicated downstream separation, it is essential to explore some environment-friendly processes such as constructing new recombinant strains to develop efficient process for trans-Hyp production. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
China | 1 | 3% |
Unknown | 33 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 29% |
Student > Master | 6 | 18% |
Researcher | 6 | 18% |
Student > Bachelor | 5 | 15% |
Lecturer | 1 | 3% |
Other | 1 | 3% |
Unknown | 5 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 38% |
Biochemistry, Genetics and Molecular Biology | 6 | 18% |
Chemistry | 6 | 18% |
Nursing and Health Professions | 1 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 1 | 3% |
Unknown | 6 | 18% |